Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10987304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

  2000cited by this paper
• Comparison of features of human lung cancer cell lines and their corresponding tumors.

  1999cited by this paper
• A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers.

  1999cited by this paper
• Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.

  1999cited by this paper
• Comparison of features of human breast cancer cell lines and their corresponding tumors.

  1999cited by this paper
• Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas.

  1999cited by this paper
• How many tumor suppressor genes are involved in human lung carcinogenesis?

  1999cited by this paper
• Novel homozygous deletions of chromosomal band 18q22 in pancreatic adenocarcinoma identified by STS marker scanning

  1999cited by this paper
• Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.

  1999cited by this paper
• Molecular pathogenesis of lung cancer.

  1999cited by this paper
• Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer

  1999cited by this paper
• Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

  1998influential reference
• Genetic instabilities in human cancers

  1998cited by this paper
• Progress in understanding the molecular pathogenesis of human lung cancer.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

  1998cited by this paper
• Allelotype and replication error phenotype of small cell lung carcinoma.

  1997cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• LOSS OF HETEROZYGOSITY AT 5q21 IN NON‐SMALL CELL LUNG CANCER: A FREQUENT EVENT BUT WITHOUT EVIDENCE OF APC MUTATION

  1996cited by this paper
• A comprehensive genetic map of the human genome based on 5,264 microsatellites

  1996cited by this paper
• Comparative allelotype of early and advanced stage non‐small cell lung carcinomas

  1996cited by this paper
• Sequential molecular genetic changes in lung cancer development.

  1995cited by this paper
• Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

  1995cited by this paper
• Somatic genetic changes in lung cancer and precancerous lesions.

  1995cited by this paper
• Molecular pathogenesis of lung cancer.

  1994cited by this paper
• Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

  1993cited by this paper
• Molecular biology: an overview.

  1992cited by this paper
• p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

  1992cited by this paper
• Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.

  1991cited by this paper
• Identification of a chromosome 18q gene that is altered in colorectal cancers.

  1990cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper

• Assessing Diversity Scaling in Lung Cancer Microbiome Across Individuals and Tissue Types

  2025cites this paper
• A review of C/EBP α: a potential novel target for solid tumor intervention

  2025influential citation
• Advances in KEAP1-based PROTACs as emerging therapeutic modalities: Structural basis and progress

  2025cites this paper
• Graph-Based Spatial Proximity of Super-Resolved Protein–Protein Interactions Predicts Cancer Drug Responses in Single Cells

  2024cites this paper
• Identifications of the potential in-silico biomarkers in lung cancer tissue microbiomes

  2024cites this paper
• Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy

  2024cites this paper
• Lung cancer clustering by identification of similarities and discrepancies of DNA copy numbers using maximal information coefficient

  2024cites this paper
• Species Diversity and Network Diversity in the Human Lung Cancer Tissue Microbiomes.

  2024cites this paper
• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report

  2024cites this paper
• Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review).

  2023cites this paper
• Shaping the tumor immune microenvironment of SCLC: Mechanisms, and opportunities for immunotherapy.

  2023cites this paper
• LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer

  2022cites this paper
• Application of Artificial Intelligence in Lung Cancer

  2022cites this paper
• LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer

  2022cites this paper
• The Role of DAPK1 in the Cell Cycle Regulation of Cervical Cancer Cells and in Response to Topotecan

  2022cites this paper
• In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer

  2022cites this paper
• The Clinicopathological Features of BRG1-de�cient Non-small Cell Lung Cancer and Its Response to Immunotherapy: A Single-center Retrospective Study

  2021cites this paper
• Targeting DNA methyltransferases in Non-small-cell lung cancer.

  2021cites this paper
• Targeting loss of heterozygosity for cancer-specific immunotherapy

  2021cites this paper
• ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma

  2021cites this paper
• The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.

  2021cites this paper
• k-core genes underpin structural features of breast cancer

  2021cites this paper
• Tumor cell‐derived angiopoietin‐like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells

  2020cites this paper
• Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations

  2019cites this paper
• Haplotype-resolved and integrated genome analysis of ENCODE cell line HepG2

  2018cites this paper
• Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype

  2018cites this paper
• MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• The evolving understanding of immunoediting and the clinical impact of immune escape.

  2018cites this paper
• Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation

  2018cites this paper
• EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways

  2018cites this paper
• Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer

  2018cites this paper
• Synchronous, Metachronous or Metastases?

  2018cites this paper
• INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases

  2018cites this paper
• Chapter 8 MIG-6 and SPRY 2 in the Regulation of Receptor Tyrosine Kinase Signaling : Balancing Act via Negative Feedback Loops

  2017cites this paper
• Cytogenetic methods and findings in human solid tumors

  2017cites this paper
• Methylation of DACT2 contributes to the progression of breast cancer through activating WNT signaling pathway.

  2017cites this paper
• A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood

  2017cites this paper
• Update on large cell neuroendocrine carcinoma.

  2017cites this paper
• Composition and Function of Mutant Swi/Snf Complexes.

  2017cites this paper
• Unravelling the biology of SCLC: implications for therapy

  2017cites this paper
• Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome

  2017cites this paper
• Effects of trigonelline inhibition of the Nrf2 transcription factor in vitro on Echinococcus granulosus

  2017cites this paper
• Examination of gene deletion as a mechanism of RBM5 downregulation in tobacco smoke-associated lung cancer

  2017cites this paper
• Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology

  2016cites this paper
• 51 – Biology of Lung Cancer

  2016cites this paper
• Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF

  2016cites this paper
• Genome-wide association study revealed genomic regions related to white/red earlobe color trait in the Rhode Island Red chickens

  2016cites this paper
• Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression

  2016cites this paper
• GADD45A expression is correlated with patient prognosis in esophageal cancer.

  2016cites this paper
• Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.

  2016cites this paper
• Copy number variation in archival melanoma biopsies versus benign melanocytic lesions

  2016cites this paper
• Polycomb and trithorax opposition in development and disease

  2016cites this paper
• Hsp 90 inhibitor NVP-AUY 922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

  2015cites this paper
• ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection

  2015cites this paper
• Biomarkers of Exposure and Susceptibility to the Tobacco Specific Nitrosamines

  2015influential citation
• Tumors of the lung

  2015cites this paper
• Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.

  2015cites this paper
• The role of Rak in the regulation of stability and function of BRCA1

  2015cites this paper
• Differential expression of inflammasomes in lung cancer cell lines and tissues

  2015cites this paper
• Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations

  2015cites this paper
• Distinguishing Melanocytic Nevi from Melanoma by DNA Copy Number Changes: Array-Comparative Genomic Hybridization as a Research Tool

  2015cites this paper
• CEBPA (CCAAT/enhancer binding protein (C/EBP), alpha)

  2015cites this paper
• miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)

  2015cites this paper
• Human sweat metabolomics for lung cancer screening

  2015cites this paper
• Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

  2015cites this paper
• Antitumor effect of afatinib , as a HER 2-targeted therapy , in lung cancers harboring HER 2 oncogene alterations

  2015cites this paper
• Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer.

  2014cites this paper
• Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia

  2014cites this paper
• USP33, a new player in lung cancer, mediates Slit-Robo signaling

  2014cites this paper
• DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers

  2014cites this paper
• Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers

  2014cites this paper
• Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma

  2014cites this paper
• Aberrant promoter methylation and gene expression of H‑cadherin gene is associated with tumor progression and recurrence in epithelial ovarian carcinoma

  2014cites this paper
• Circulating tumor cells from a 4-dimensional lung cancer model are resistant to cisplatin.

  2014cites this paper
• Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review).

  2014cites this paper
• Identification and Characteristics of Factors Regulating Hepatocellular Carcinoma Progression and Metastasis: A Dissertation

  2014cites this paper
• Estudio de las alteraciones genéticas en adenocarcinomas gástricos mediante aCGH y FISH en su contexto clínico-patológico

  2014cites this paper
• CD44 promotes Kras-dependent lung adenocarcinoma

  2013cites this paper
• Aberrant methylation of SPARC in human lung cancers

  2013cites this paper
• mTOR inhibitors radiosensitize PTEN‐deficient non‐small‐cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy

  2013cites this paper
• miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.

  2013cites this paper
• Transforming acidic coiled-coil proteins (TACCs) in human cancer.

  2013cites this paper
• Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer

  2013cites this paper
• Src Mediates Cigarette Smoke–Induced Resistance to Tyrosine Kinase Inhibitors in NSCLC Cells

  2013cites this paper
• MIG-6 and SPRY2 in the Regulation of Receptor Tyrosine Kinase Signaling: Balancing Act via Negative Feedback Loops

  2013cites this paper
• Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

  2013cites this paper
• Molecular pathology of lung cancer

  2013cites this paper
• Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

  2013cites this paper
• Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls

  2013cites this paper
• An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer

  2013cites this paper
• Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis

  2013cites this paper
• Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study

  2013cites this paper
• [Allelic imbalance in patients with non-small cell lung cancer].

  2013cites this paper
• Control of the tumor suppressor p53 by regulating Mdm2 activity and stability

  2013cites this paper
• RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53.

  2013cites this paper
• MicroRNAs as molecular markers in lung cancer

  2013cites this paper
• Molecular and Cellular Pathobiology miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma , Where It Interferes with Cell-Cycle Regulation

  2013cites this paper
• Lung cancer biomarker discovery using proteomic techniques

  2013cites this paper